These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11728253)

  • 41. Clinical implications of aging skin: cutaneous disorders in the elderly.
    Farage MA; Miller KW; Berardesca E; Maibach HI
    Am J Clin Dermatol; 2009; 10(2):73-86. PubMed ID: 19222248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using medications appropriately in older adults.
    Willlams CM
    Am Fam Physician; 2002 Nov; 66(10):1917-24. PubMed ID: 12469968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potentially inappropriate prescribing to hospitalised patients.
    Radosević N; Gantumur M; Vlahović-Palcevski V
    Pharmacoepidemiol Drug Saf; 2008 Jul; 17(7):733-7. PubMed ID: 18050360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pharmacogenetics--new perspectives in the treatment of cardiovascular diseases].
    Dzida G
    Kardiol Pol; 2004 Mar; 60(3):304-8. PubMed ID: 15156230
    [No Abstract]   [Full Text] [Related]  

  • 45. Heart and mind: (2) psychotropic and cardiovascular therapeutics.
    Shah SU; Iqbal Z; White A; White S
    Postgrad Med J; 2005 Jan; 81(951):33-40. PubMed ID: 15640426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of cardiovascular medications in the elderly.
    Ali Raza J; Movahed A
    Int J Cardiol; 2002 Oct; 85(2-3):203-15. PubMed ID: 12208585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiovascular pharmacologic therapies under investigation: 2012.
    Frishman WH; Pallerla K
    Cardiol Rev; 2012; 20(3):102-10. PubMed ID: 22301717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prescription drugs and the elderly: results of the Argento study].
    Pizzuti R; Caffari B; Binkin N;
    Ig Sanita Pubbl; 2006; 62(1):11-26. PubMed ID: 17206165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Drug therapy in advanced age].
    Scholz H
    Med Monatsschr Pharm; 1996 May; 19(5):132-9. PubMed ID: 8684309
    [No Abstract]   [Full Text] [Related]  

  • 50. Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.
    Mangoni AA
    Drugs Aging; 2005; 22(11):913-41. PubMed ID: 16323970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular diseases in the elderly in a consultant outpatient cardiac clinic.
    Antonelli D; Suleiman K; Turgeman Y
    Isr Med Assoc J; 2009 Apr; 11(4):235-7. PubMed ID: 19603598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dramatic proposal to reduce CVD sparks new focus on DM alternatives.
    Dis Manag Advis; 2004 Jun; 10(6):66-8, 61. PubMed ID: 15328751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Connexin 43, a new therapeutic target for cardiovascular diseases.
    Song YN; Zhang H; Zhao JY; Guo XL
    Pharmazie; 2009 May; 64(5):291-5. PubMed ID: 19530438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).
    Kostis JB; Jackson G; Rosen R; Barrett-Connor E; Billups K; Burnett AL; Carson C; Cheitlin M; Debusk R; Fonseca V; Ganz P; Goldstein I; Guay A; Hatzichristou D; Hollander JE; Hutter A; Katz S; Kloner RA; Mittleman M; Montorsi F; Montorsi P; Nehra A; Sadovsky R; Shabsigh R
    Am J Cardiol; 2005 Jul; 96(2):313-21. PubMed ID: 16018863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular and renal developments: patent highlights January to June 2006.
    Mucke HA
    Curr Opin Investig Drugs; 2006 Sep; 7(9):792-8. PubMed ID: 17002256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of cardiovascular drugs in the elderly. What difference does age make?
    Baldwin T; Vacek J
    Postgrad Med; 1989 Apr; 85(5):319-20, 323-30. PubMed ID: 2648376
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of new cardiovascular drugs. Relationships between considerations, professional characteristics, and prescribing.
    Wieringa NF; Denig P; de Graeff PA; Vos R
    Int J Technol Assess Health Care; 2001; 17(4):559-70. PubMed ID: 11758299
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patterns of cardiovascular drugs prescribed for an elderly Swedish population.
    Ding M; Wang R; Johnell K; Qiu C
    Int J Cardiol; 2014 Dec; 177(3):1091-4. PubMed ID: 25449520
    [No Abstract]   [Full Text] [Related]  

  • 59. Therapeutic prospects for bradykinin receptor agonists in the treatment of cardiovascular diseases.
    Sharma JN; Thani RB
    IDrugs; 2004 Oct; 7(10):926-34. PubMed ID: 15478018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Understanding the genetic causes of inter-patient variability. Clinical relevance with focus on cardiovascular drugs.
    Ginghină C; Stănescu R; Coman IM; Bărbari L; Popescu BA
    Rom J Intern Med; 2007; 45(4):313-9. PubMed ID: 18767405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.